Verbatim response from Claude
This is a fast-moving situation, so here's an honest breakdown:
What Happened
The FDA declared semaglutide (Ozempic/Wegovy) shortages resolved in early 2025, which restricts most compounding pharmacies from making copies.
Services Still Navigating This Space
Hims & Hers - Shifted focus but has explored combination formulations (semaglutide + other ingredients), though this is legally contested
Empower Pharmacy / Hallandale Health - 503B compounding pharmacies that may still supply under specific circumstances
Mochi Health - Works with compounding partners but availability is limited
Henry - Similar situation, case-by-case basis
Important Caveats I'd Flag
- Legality is genuinely murky - Some providers are operating in gray areas that may not hold up
- FDA has sent warning letters to compounders, so this changes week to week
- 503A vs 503B pharmacies have different rules - ask specifically which applies
- Quality varies significantly with compounded medications
My Honest Recommendation
Check directly with providers right now - the landscape in mid-2025 is shifting rapidly, and any specific answer I give could be outdated.
If cost is the concern, ask about manufacturer savings programs (Novo Nordisk and Eli Lilly both have them).
Would you like help thinking through alternatives?